ArticleBriefings in bioinformatics2025
DeepTFtyper: an interpretable morphology-aware graph neural network for translating histopathology images into molecular subtypes in small cell lung cancer.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A new era of precision diagnosis and treatment for lung cancer: artificial intelligence-driven multimodal data integration and clinical applications.Cell death & disease · 2026Review
- Graph convolutional network-derived pathomics and clinical integration for predicting chemoimmunotherapy response in advanced lung squamous cell carcinoma: a multicenter study.Journal of translational medicine · 2026Article
- Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer.NPJ precision oncology · 2026Article
- AI-assisted multimodal data integration for precision oncology.Frontiers in artificial intelligence · 2026Review
- A Deep Learning Framework for Classification of Neuroendocrine Neoplasm Whole Slide Images.Cancers · 2025Article
- Deep learning-based histomorphological subtyping and risk stratification of small cell lung cancer from hematoxylin and eosin-stained whole slide images.Genome medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Small cell lung cancer (SCLC) is a highly aggressive high-grade neuroendocrine carcinoma with a poor prognosis. Molecular subtyping of transcription factors (SCLC-A, -N, -P, and -Y) shows great potential for guiding treatment decisions. However, its clinical application are limited by insufficient samples and the complexity of molecular testing. In this study, we developed DeepTFtyper, a graph neural network-based deep learning model for automatically classifying SCLC molecular subtypes from hematoxylin and eosin-stained whole-slide images. DeepTFtyper was trained and tested on the Cancer Hospital, Chinese Academy of Medical Science cohort (n = 389) with 4-fold cross-validation, and achieved high performance with an area under the receiver operating characteristic curve above 0.70 for all four molecular subtypes identified by immunohistochemistry (IHC). Furthermore, the digital H-scores predicted by DeepTFtyper showed a significant correlation with IHC-based H-scores. Patch-level visualization and morphological analysis revealed that DeepTFtyper identifies interpretable and generalizable features corresponding to areas of relevant transcription factor expression as revealed by IHC staining and correlates well with morphological features. This study represents the first deep learning framework for predicting SCLC molecular subtypes from hematoxylin and eosin-stained histology slides, providing a scalable, accurate, and clinically relevant tool to improve patient management and guide personalized treatment decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.